Cargando…

Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT

The menopausal transition is a critical period in women’s lives. Exercise might be the most promising non-pharmaceutic intervention to address the large variety of risk factors related to the pronounced estradiol decline during peri- and early-postmenopause. The aim of this study was to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hettchen, Michael, von Stengel, Simon, Kohl, Matthias, Murphy, Marie H, Shojaa, Mahdieh, Ghasemikaram, Mansour, Bragonzoni, Laura, Benvenuti, Francesco, Ripamonti, Claudio, Benedetti, Maria Grazia, Julin, Mikko, Risto, Tapani, Kemmler, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810823/
https://www.ncbi.nlm.nih.gov/pubmed/33469276
http://dx.doi.org/10.2147/CIA.S283177
_version_ 1783637376091815936
author Hettchen, Michael
von Stengel, Simon
Kohl, Matthias
Murphy, Marie H
Shojaa, Mahdieh
Ghasemikaram, Mansour
Bragonzoni, Laura
Benvenuti, Francesco
Ripamonti, Claudio
Benedetti, Maria Grazia
Julin, Mikko
Risto, Tapani
Kemmler, Wolfgang
author_facet Hettchen, Michael
von Stengel, Simon
Kohl, Matthias
Murphy, Marie H
Shojaa, Mahdieh
Ghasemikaram, Mansour
Bragonzoni, Laura
Benvenuti, Francesco
Ripamonti, Claudio
Benedetti, Maria Grazia
Julin, Mikko
Risto, Tapani
Kemmler, Wolfgang
author_sort Hettchen, Michael
collection PubMed
description The menopausal transition is a critical period in women’s lives. Exercise might be the most promising non-pharmaceutic intervention to address the large variety of risk factors related to the pronounced estradiol decline during peri- and early-postmenopause. The aim of this study was to determine the effect of an 18-month multipurpose exercise program on risk factors and symptoms related to the menopausal transition. Fifty-four women 1–5 years postmenopause with osteopenia or osteoporosis were randomly assigned 1) to a high impact weight-bearing/high-intensity/velocity resistance training group (EG: n=27) exercising three times a week or 2) to an attendance control group (CG: n=27) that performed low-intensity exercise once a week. Both groups were supplemented with cholecalciferol and calcium. The primary study endpoint was bone mineral density (BMD) at lumbar spine (LS) and total hip, secondary outcomes were lean body mass (LBM), total and abdominal body percentage, metabolic syndrome Z-Score (MetS-Z), menopausal symptoms and muscle strength and power. Due to COVID-19, the study was stopped after 13 months. We observed significant effects for BMD-LS (EG: 0.002±.018 versus CG: −.009±0.018 mg/cm2, p=0.027) but not for BMD total hip (EG: −0.01±.016 versus CG: −.009±0.020 mg/cm2, p=0.129). LBM improved significantly in the EG and decreased in the CG (0.39±1.08 vs −0.37±1.34 kg, p=0.026). Total and abdominal body fat improved significantly in the EG and was maintained in the CG (−1.44±1.49 vs −0.02±1.55 kg, p=0.002 and -1.50±2.33 vs 0.08±2.07 kg, p=0.011). Significant effects in favor of the EG were also determined for menopausal symptoms (p=0.029), hip/leg extension strength (p<0.001) and power (p<0.001). However, changes of the MetS-Z did not differ significantly (p=0.149) between EG and CG. In summary, with minor exceptions, we demonstrated the effectiveness of a multipurpose exercise protocol dedicated to early-postmenopausal women on various risk factors and complaints related to the menopausal transition.
format Online
Article
Text
id pubmed-7810823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78108232021-01-18 Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT Hettchen, Michael von Stengel, Simon Kohl, Matthias Murphy, Marie H Shojaa, Mahdieh Ghasemikaram, Mansour Bragonzoni, Laura Benvenuti, Francesco Ripamonti, Claudio Benedetti, Maria Grazia Julin, Mikko Risto, Tapani Kemmler, Wolfgang Clin Interv Aging Clinical Trial Report The menopausal transition is a critical period in women’s lives. Exercise might be the most promising non-pharmaceutic intervention to address the large variety of risk factors related to the pronounced estradiol decline during peri- and early-postmenopause. The aim of this study was to determine the effect of an 18-month multipurpose exercise program on risk factors and symptoms related to the menopausal transition. Fifty-four women 1–5 years postmenopause with osteopenia or osteoporosis were randomly assigned 1) to a high impact weight-bearing/high-intensity/velocity resistance training group (EG: n=27) exercising three times a week or 2) to an attendance control group (CG: n=27) that performed low-intensity exercise once a week. Both groups were supplemented with cholecalciferol and calcium. The primary study endpoint was bone mineral density (BMD) at lumbar spine (LS) and total hip, secondary outcomes were lean body mass (LBM), total and abdominal body percentage, metabolic syndrome Z-Score (MetS-Z), menopausal symptoms and muscle strength and power. Due to COVID-19, the study was stopped after 13 months. We observed significant effects for BMD-LS (EG: 0.002±.018 versus CG: −.009±0.018 mg/cm2, p=0.027) but not for BMD total hip (EG: −0.01±.016 versus CG: −.009±0.020 mg/cm2, p=0.129). LBM improved significantly in the EG and decreased in the CG (0.39±1.08 vs −0.37±1.34 kg, p=0.026). Total and abdominal body fat improved significantly in the EG and was maintained in the CG (−1.44±1.49 vs −0.02±1.55 kg, p=0.002 and -1.50±2.33 vs 0.08±2.07 kg, p=0.011). Significant effects in favor of the EG were also determined for menopausal symptoms (p=0.029), hip/leg extension strength (p<0.001) and power (p<0.001). However, changes of the MetS-Z did not differ significantly (p=0.149) between EG and CG. In summary, with minor exceptions, we demonstrated the effectiveness of a multipurpose exercise protocol dedicated to early-postmenopausal women on various risk factors and complaints related to the menopausal transition. Dove 2021-01-11 /pmc/articles/PMC7810823/ /pubmed/33469276 http://dx.doi.org/10.2147/CIA.S283177 Text en © 2021 Hettchen et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Clinical Trial Report
Hettchen, Michael
von Stengel, Simon
Kohl, Matthias
Murphy, Marie H
Shojaa, Mahdieh
Ghasemikaram, Mansour
Bragonzoni, Laura
Benvenuti, Francesco
Ripamonti, Claudio
Benedetti, Maria Grazia
Julin, Mikko
Risto, Tapani
Kemmler, Wolfgang
Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title_full Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title_fullStr Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title_full_unstemmed Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title_short Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
title_sort changes in menopausal risk factors in early postmenopausal osteopenic women after 13 months of high-intensity exercise: the randomized controlled actlife-rct
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810823/
https://www.ncbi.nlm.nih.gov/pubmed/33469276
http://dx.doi.org/10.2147/CIA.S283177
work_keys_str_mv AT hettchenmichael changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT vonstengelsimon changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT kohlmatthias changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT murphymarieh changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT shojaamahdieh changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT ghasemikarammansour changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT bragonzonilaura changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT benvenutifrancesco changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT ripamonticlaudio changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT benedettimariagrazia changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT julinmikko changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT ristotapani changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct
AT kemmlerwolfgang changesinmenopausalriskfactorsinearlypostmenopausalosteopenicwomenafter13monthsofhighintensityexercisetherandomizedcontrolledactliferct